7,428 followers
Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma https://t.co/4YA4vxpm8j
Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma https://t.co/4YA4vxpm8j
RT @StojdlLab: Pairing 1st-line renal cell #cancer drug, sunitinib, with #oncolytic reovirus potentiates immunotherapeutic efficacy https:/…
RT @StojdlLab: Pairing 1st-line renal cell #cancer drug, sunitinib, with #oncolytic reovirus potentiates immunotherapeutic efficacy https:/…
Pairing 1st-line renal cell #cancer drug, sunitinib, with #oncolytic reovirus potentiates immunotherapeutic efficacy https://t.co/aW2uVfVpHN